Global Gene Therapy Platform Market Size To Exceed USD 9.84 Billion By 2035 | CAGR Of 15.12%
Category: HealthcareGlobal Gene Therapy Platform Market Size To Exceed USD 9.84 Billion By 2035
According to a Research Report Published by Spherical Insights & Consulting, The Global Gene Therapy Platform Market Size is Expected to Grow from USD 2.09 Billion in 2024 to USD 9.84 Billion by 2035, at a CAGR of 15.12% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 250 pages with 120 Market data tables and figures & charts from the report on the "Global Gene Therapy Platform Market Size, Share, and COVID-19 Impact Analysis, By Platform Type (Viral Vector Platforms, Non-Viral Vector Platforms, and Gene Editing Platforms), By Application (Oncology, Rare Genetic Disorders, Cardiovascular Diseases, Neurological Disorders, Ophthalmic Diseases, Hematological Disorders, Musculoskeletal Disorders, and Infectious Diseases), By Delivery Mode (In Vivo Gene Therapy, Ex Vivo Gene Therapy, and Others), By End Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Development & Manufacturing Organizations (CDMOs), and Hospitals & Gene Therapy Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/gene-therapy-platform-market
The Gene Therapy Platform Market Size refers to a comprehensive technological framework or system for introducing therapeutic genetic material into a patient's cells in order to treat or prevent disease. This platform frequently includes delivery vectors (e.g., viral or non-viral systems), gene-editing tools (e.g., CRISPR-Cas9), manufacturing processes, and regulatory requirements for creating, testing, and commercializing gene therapy products. The market growth is driven by technological advancements, an increase in inherited and chronic illnesses, and substantial financial support for biopharmaceutical research. Advances in industrial efficiency, AI integration, and gene editing technologies are speeding up development and accuracy. Regulatory bodies are promoting this growth and market expansion by offering incentives and expedited permits. Notable FDA approvals, such as Casgevy for sickle cell disease, demonstrate the therapeutic promise of gene therapy. However, the market growth is hindered by the high production cost and high maintenance.
The viral vector platforms segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the platform type, the gene therapy platform market is classified into viral vector platforms, non-viral vector platforms, and gene editing platforms. Among these, the viral vector platforms segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth can be attributed to their high transduction efficiency, targeted delivery, and sustained gene expression. GMP production is being sped up and made simpler by technological advancements like AGC Biologics' BravoAAV and ProntoLVV platforms. Expanding clinical applications across a variety of therapeutic contexts requires these advancements.
The oncology segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the application, the gene therapy platform market is divided into oncology, rare genetic disorders, cardiovascular diseases, neurological disorders, ophthalmic diseases, hematological disorders, musculoskeletal disorders, and infectious diseases. Among these, the oncology segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The growth is driven by the increasing need for customized, specialized cancer treatments. Important motivators include advancements in CRISPR gene editing, CAR-T cell therapy, and other gene modification technologies that make more effective treatments possible. Additionally, the industry continues to expand due to developments in gene therapy.
The in vivo gene therapy segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the delivery mode, the gene therapy platform market is classified into in vivo gene therapy, ex vivo gene therapy, and others. Among these, the in vivo gene therapy segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth can be attributed to the direct implantation of genetic material into the patient's body; in vivo gene therapy offers a more targeted and effective approach. The successful treatment of genetic illnesses and advancements in vector technology are driving its adoption. The search for long-lasting medicines is accelerating thanks to new platforms like Stylus Medicine, which increase precision and scalability.
The pharmaceutical & biotechnology companies segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the end use, the gene therapy platform market is classified into pharmaceutical & biotechnology companies, academic & research institutions, contract development & manufacturing organizations (CDMOs), and hospitals & gene therapy centers. Among these, the pharmaceutical & biotechnology companies segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth can be attributed to their significant R&D investments, advanced production capabilities, and crucial clinical paths. Pharmaceutical and biotech companies are investing heavily in state-of-the-art vector engineering technologies to increase the safety, effectiveness, and specificity of gene therapies.
North America is anticipated to hold the largest share of the gene therapy platform market over the predicted timeframe.
Get more details on this report -
North America is anticipated to hold the largest share of the gene therapy platform market over the predicted timeframe. The regional growth can be attributed to the benefits of a robust biotech industry, significant R&D investments, and a favorable regulatory environment in the region. The U.S. FDA has created faster pathways for gene therapy, such as RMAT and Breakthrough Therapy Designation, to encourage innovation. High-profile approvals, such as CRISPR-based therapies for sickle cell disease and beta-thalassemia, show North America's leadership.
Asia Pacific is expected to grow at a rapid CAGR in the gene therapy platform market during the forecast period. The region's growth is being driven by the simplified gene therapy rules, especially in China and South Korea, which have led to an upsurge in clinical investigations. Chinese businesses like Legend Biotech and JW Therapeutics are working with Western businesses to develop indigenous medicines in order to increase capacity. Furthermore, due to its large patient base, government-led genomics initiatives, and CDMO expansion, India is emerging as a center for clinical trials and manufacturing.
Major vendors in the global gene therapy platform market are Lonza, Renova Therapeutics, BioIT, Andelyn Biosciences, Autolomous Ltd, AstraZeneca, Hypertrust Patient Data Care (Part of Accenture), Precision BioSciences, IBM, CRISPR Therapeutics, L7 Informatics, Inc., Sarepta Therapeutics, Inc., TrakCel, ElevateBio, IDBS, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In February 2025, Andelyn Biosciences improves gene therapy innovation by expanding its AAV Curator platform. The arrangement allows Andelyn to employ Stanton Lab CNS capsids for research and development activities on behalf of clients developing gene treatments.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the gene therapy platform market based on the below-mentioned segments:
Global Gene Therapy Platform Market, By Platform Type
- Viral Vector Platforms
- Non-Viral Vector Platforms
- Gene Editing Platforms
Global Gene Therapy Platform Market, By Application
- Oncology
- Rare Genetic Disorders
- Cardiovascular Diseases
- Neurological Disorders
- Ophthalmic Diseases
- Hematological Disorders
- Musculoskeletal Disorders
- Infectious Diseases
Global Gene Therapy Platform Market, By Delivery Mode
- In Vivo Gene Therapy
- Ex Vivo Gene Therapy
- Others
Global Gene Therapy Platform Market, By End Use
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutions
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals & Gene Therapy Centers
Global Gene Therapy Platform Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?